Genesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Residential & Long Term Care
- Sub-Industry: N/A
- Symbol: NYSE:GEN
- CUSIP: N/A
- Web: www.genesishcc.com
Capitalization:- Market Cap: $97.56 million
- Outstanding Shares: 94,721,000
Average Prices:- 50 Day Moving Avg: $1.15
- 200 Day Moving Avg: $1.87
- 52 Week Range: $0.91 - $4.75
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.16
- P/E Growth: -0.07
Sales & Book Value:- Annual Revenue: $5.45 billion
- Price / Sales: 0.02
- Book Value: ($6.52) per share
- Price / Book: -0.16
Profitability:- EBIDTA: $450.3 million
- Net Margins: -2.05%
- Return on Assets: -2.71%
Debt:- Debt-to-Equity Ratio: -5.49%
- Current Ratio: 1.26%
- Quick Ratio: 1.26%
Misc:- Average Volume: 655,161 shs.
- Beta: 1.18
- Short Ratio: 1.63
Frequently Asked Questions for Genesis Healthcare (NYSE:GEN)
What is Genesis Healthcare's stock symbol?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."
How were Genesis Healthcare's earnings last quarter?
Genesis Healthcare, Inc. (NYSE:GEN) released its earnings results on Thursday, November, 3rd. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.40) by $0.17. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.39 billion. The business's revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.07 EPS. View Genesis Healthcare's Earnings History.
Where is Genesis Healthcare's stock going? Where will Genesis Healthcare's stock price be in 2017?
2 brokers have issued 1 year price objectives for Genesis Healthcare's shares. Their predictions range from $2.00 to $2.00. On average, they anticipate Genesis Healthcare's stock price to reach $2.00 in the next twelve months. View Analyst Ratings for Genesis Healthcare.
Who are some of Genesis Healthcare's key competitors?
Some companies that are related to Genesis Healthcare include Signal Genetics (MGEN), Merrimack Pharmaceuticals (MACK), Compugen (CGEN), Aileron Therapeutics (ALRN), Advaxis (ADXS), Osiris Therapeutics (OSIR), Ocular Therapeutix (OCUL), Verastem (VSTM), Threshold Pharmaceuticals (MTEM), Anavex Life Sciences Corp. (AVXL), Concord Medical Services Holdings Limited (CCM), Kamada (KMDA), Quotient Limited (QTNT), OncoMed Pharmaceuticals (OMED), Fate Therapeutics (FATE), Viralytics (VRACY), Majesco Entertainment Company (COOL) and Vascular Biogenics (VBLT).
Who are Genesis Healthcare's key executives?
Genesis Healthcare's management team includes the folowing people:
- Robert H. Fish, Chairman of the Board
- Paul David Bach, President, Executive Vice President
- George V. Hager Jr., Chief Executive Officer, Director
- Thomas DiVittorio, Chief Financial Officer, Treasurer, Assistant Secretary
- Daniel Allen Hirschfeld, President - Genesis Rehab Services
- Stephen Saville, President of Career Staff Unlimited
- Jeanne Phillips, Chief Human Resource Officer
- David C. Almquist, Executive Vice President, President West Division
- Richard P. Blinn, Executive Vice President, President Northeast Division
- Raymond L. Thivierge, Executive Vice President - West Division
Who owns Genesis Healthcare stock?
Genesis Healthcare's stock is owned by many different of institutional and retail investors. Top institutional investors include
FISHMAN STEVEN E.
(64.80%),
ONEX CORP
(14.20%),
ONEX CORP
(13.20%), HighTower Advisors LLC (4.00%), First Washington CORP (2.12%) and JPMorgan Chase & Co. (1.54%). Company insiders that own Genesis Healthcare stock include Daniel Allen Hirschfeld, George V Hager Jr, James V Mckeon, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.
Who sold Genesis Healthcare stock? Who is selling Genesis Healthcare stock?
Genesis Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Dimensional Fund Advisors LP, TIAA CREF Investment Management LLC, Citadel Advisors LLC, Acadian Asset Management LLC, OxFORD Asset Management LLP, Bank of New York Mellon Corp and California Public Employees Retirement System. Company insiders that have sold Genesis Healthcare stock in the last year include Daniel Allen Hirschfeld, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.
Who bought Genesis Healthcare stock? Who is buying Genesis Healthcare stock?
Genesis Healthcare's stock was purchased by a variety of institutional investors in the last quarter, including First Washington CORP, JPMorgan Chase & Co., Virtu KCG Holdings LLC, SG Americas Securities LLC, BSW Wealth Partners, Great West Life Assurance Co. Can, Northern Trust Corp and State Street Corp. Company insiders that have bought Genesis Healthcare stock in the last two years include James V Mckeon and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.
How do I buy Genesis Healthcare stock?
Shares of Genesis Healthcare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Genesis Healthcare's stock price today?
One share of Genesis Healthcare stock can currently be purchased for approximately $1.03.
MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Genesis Healthcare (NYSE:GEN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 1 Buy Rating |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | $2.00 (94.17% upside) |
Analysts' Ratings History for Genesis Healthcare (NYSE:GEN)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/13/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $2.00 | Low |  |
| 7/5/2017 | Cantor Fitzgerald | Initiated Coverage | Overweight | | High | |
| 9/19/2016 | Bank of America Corporation | Set Price Target | Sell | $1.80 | N/A | |
| 5/11/2016 | Stephens | Downgrade | Overweight -> Hold | | N/A | |
| 1/26/2016 | Susquehanna Bancshares Inc | Lower Price Target | Neutral | $5.50 -> $2.75 | N/A | |
(Data available from 9/26/2015 forward)
Earnings History for Genesis Healthcare (NYSE:GEN)Earnings History by Quarter for Genesis Healthcare (NYSE GEN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/9/2017 | Q1 17 | ($0.25) | ($0.50) | $1.40 billion | $1.39 billion | View | Listen | |
| 11/3/2016 | Q3 | ($0.40) | ($0.23) | $1.39 billion | $1.42 billion | View | N/A | |
| 8/4/2016 | Q2 | $0.01 | ($0.26) | $1.40 billion | $1.44 billion | View | N/A | |
| 5/9/2016 | Q1 | $0.03 | ($0.01) | $1.43 billion | $1.47 billion | View | N/A | |
| 11/5/2015 | Q315 | $0.07 | $0.07 | $1.42 billion | $1.42 billion | View | N/A | |
| 8/6/2015 | Q215 | $0.09 | $0.14 | $1.43 billion | $1.41 billion | View | N/A | |
| 2/19/2015 | Q412 | $0.14 | $0.14 | $209.50 million | $1.19 billion | View | N/A | |
| 11/9/2012 | Q312 | $0.03 | $0.18 | $935.06 million | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Genesis Healthcare (NYSE:GEN)Current Year EPS Consensus Estimate: $-1.45 EPS
Next Year EPS Consensus Estimate: $-0.89 EPS
Dividend History for Genesis Healthcare (NYSE:GEN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Genesis Healthcare (NYSE:GEN)Insider Ownership Percentage: 57.59%
Institutional Ownership Percentage: 14.90%
Insider Trades by Quarter for Genesis Healthcare (NYSE:GEN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/14/2017 | Joanne Susan Reifsnyder | EVP | Sell | 5,269 | $1.73 | $9,115.37 | |
| 6/14/2017 | Michael Scott Sherman | SVP | Sell | 3,903 | $1.73 | $6,752.19 | |
| 6/14/2017 | Paul David Bach | COO | Sell | 6,100 | $1.73 | $10,553.00 | |
| 6/14/2017 | Stephen Scott Young | VP | Sell | 3,799 | $1.73 | $6,572.27 | |
| 6/14/2017 | Thomas Divittorio | CFO | Sell | 6,341 | $1.73 | $10,969.93 | |
| 6/7/2017 | Daniel Allen Hirschfeld | COO | Sell | 2,895 | $1.61 | $4,660.95 | |
| 6/7/2017 | Joanne Susan Reifsnyder | EVP | Sell | 2,383 | $1.61 | $3,836.63 | |
| 6/7/2017 | Michael Scott Sherman | SVP | Sell | 1,824 | $1.61 | $2,936.64 | |
| 6/7/2017 | Stephen Scott Young | VP | Sell | 1,541 | $1.61 | $2,481.01 | |
| 6/7/2017 | Thomas Divittorio | CFO | Sell | 2,900 | $1.61 | $4,669.00 | |
| 8/29/2016 | Stephen Scott Young | VP | Sell | 10,000 | $2.38 | $23,800.00 | |
| 6/8/2016 | Daniel Allen Hirschfeld | COO | Sell | 3,009 | $1.72 | $5,175.48 | |
| 6/8/2016 | George V Hager Jr | CEO | Sell | 6,031 | $1.72 | $10,373.32 | |
| 6/8/2016 | Joanne Susan Reifsnyder | EVP | Sell | 2,207 | $1.72 | $3,796.04 | |
| 6/8/2016 | Michael Scott Sherman | SVP | Sell | 1,919 | $1.72 | $3,300.68 | |
| 6/8/2016 | Stephen Scott Young | VP | Sell | 1,621 | $1.72 | $2,788.12 | |
| 6/8/2016 | Thomas Divittorio | CFO | Sell | 3,051 | $1.72 | $5,247.72 | |
| 11/12/2015 | James V Mckeon | Director | Buy | 10,000 | $4.15 | $41,500.00 | |
| 11/11/2015 | Thomas Divittorio | CFO | Buy | 20,000 | $4.34 | $86,800.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Genesis Healthcare (NYSE:GEN)
Latest Headlines for Genesis Healthcare (NYSE:GEN)
| Source: |
|
| Date | Headline |
|---|
 | BRIEF-Sabra moves through Sabra 2.0 with the CCP acquisition to Sabra 3.0
www.reuters.com - September 25 at 5:29 PM |
 | Genesis Healthcare To Present Cantor Fitzgerald Conference; Webcast At 3:00 PM
www.nasdaq.com - September 25 at 5:29 PM |
 | Form 8-K Genesis Healthcare, Inc. For: Sep 22 - StreetInsider.com - StreetInsider.com
www.streetinsider.com - September 23 at 12:43 AM |
| BRIEF-Sabra enters into agreements to acquire 49 pct equity interest in senior housing joint ventures managed by Enlivant
www.reuters.com - September 19 at 6:58 PM |
 | CloudMine Honored as Health Care Innovator by Philadelphia Business Journal
www.prnewswire.com - September 18 at 11:37 PM |
 | Genesis Rehab Services Honored by Philadelphia Business Journal as a 2017 Health Care Innovator
finance.yahoo.com - September 18 at 6:35 PM |
 | Genesis Healthcare, Inc. (GEN) Receives Hold Rating from Royal Bank Of Canada
www.americanbankingnews.com - September 13 at 9:44 PM |
| Genesis HealthCare Opens 11th PowerBack Rehabilitation Location
finance.yahoo.com - September 12 at 7:48 PM |
 | Health Care Heroes award winner: Genesis Medical Associates Inc.
www.bizjournals.com - September 12 at 12:32 AM |
| Genesis HealthCare Applauds Employee Response to Hurricane Harvey
finance.yahoo.com - September 8 at 7:28 PM |
| Sabra Health Care REIT (SBRA) Offers Update on CCP Portfolio Repositioning, FY17 & FY18 Outlook
www.streetinsider.com - September 7 at 7:09 PM |
| Sabra Provides Update on Care Capital Properties (“CCP”) Portfolio ...
www.nasdaq.com - September 7 at 7:09 PM |
| Financial Analysis: Genesis Healthcare (GEN) & Five Star Senior Living (FVE)
www.americanbankingnews.com - August 29 at 8:40 AM |
| Troubled Eagle Crest nursing home to close, resulting in 72 layoffs
www.bizjournals.com - August 28 at 6:40 PM |
 | Fujifilm Secures DIN-PACS IV Contract from U.S. Department of Defense
www.businesswire.com - August 25 at 5:47 AM |
| Genesis Healthcare, Pioneer in Genetic Health Testing, Announces 1.4 Bil. Yen New Share Issue to Rakuten - PR Newswire (press release)
www.prnewswire.com - August 23 at 7:42 AM |
| Genesis Healthcare (GEN) and Five Star Senior Living (FVE) Financial Analysis
www.americanbankingnews.com - August 15 at 10:58 AM |
| CoinMD Mines Genesis Block at Public Event
www.streetinsider.com - August 12 at 12:26 AM |
| Genesis to continue divestment strategy into 2018
www.bizjournals.com - August 10 at 11:26 PM |
| Edited Transcript of GEN earnings conference call or presentation 9-Aug-17 12:30pm GMT
finance.yahoo.com - August 10 at 12:11 AM |
| Investor Network: Genesis Healthcare Inc Class A to Host Earnings Call
finance.yahoo.com - August 9 at 7:09 PM |
| See what the IHS Markit Score report has to say about Genesis Healthcare Inc.
finance.yahoo.com - August 9 at 7:09 PM |
 | EARNINGS SUMMARY: Details of Genesis Healthcare Inc. Q2 Earnings Report
www.rttnews.com - August 9 at 4:42 AM |
| Genesis HealthCare Reports Second Quarter 2017 Results
finance.yahoo.com - August 8 at 11:41 PM |
| Genesis Healthcare reports 2Q loss
finance.yahoo.com - August 8 at 11:41 PM |
| Genesis Healthcare (SKH) vs. Genesis Healthcare (GEN) Head to Head Comparison
www.americanbankingnews.com - August 8 at 6:26 PM |
| Genesis Healthcare (SKH) vs. Genesis Healthcare (GEN) Head-To-Head Contrast
www.americanbankingnews.com - August 6 at 12:30 AM |
| Critical Survey: Civitas Solutions (CIVI) versus Genesis Healthcare (NYSE:GEN)
www.americanbankingnews.com - August 2 at 7:58 AM |
| Head-To-Head Review: Genesis Healthcare (NYSE:GEN) versus Brookdale Senior Living (BKD)
www.americanbankingnews.com - July 28 at 8:10 AM |
| Critical Comparison: Omnicare (OCR) vs. Genesis Healthcare (GEN)
www.americanbankingnews.com - July 25 at 8:30 AM |
 | Eminence Capital Plans to Vote Against Sabra's Care Capital Deal - Bloomberg
www.bloomberg.com - July 24 at 9:12 AM |
 | Omega Healthcare: What Is The Worst That Could Happen?
seekingalpha.com - July 20 at 12:44 AM |
| Eight Genesis HealthCare Centers Receive Silver National Quality Award
finance.yahoo.com - July 10 at 6:57 PM |
| Head-To-Head Contrast: Genesis Healthcare (GEN) and Brookdale Senior Living (BKD)
www.americanbankingnews.com - July 9 at 8:23 AM |
 | Benzinga's Top Upgrades, Downgrades For July 6, 2017 - Benzinga
www.benzinga.com - July 7 at 2:13 AM |
| Genesis Healthcare, Inc. (NYSE:GEN) Coverage Initiated by Analysts at Cantor Fitzgerald
www.americanbankingnews.com - July 5 at 9:20 PM |
| Six Genesis HealthCare Centers Receive Bronze National Quality Award
finance.yahoo.com - June 28 at 6:40 PM |
| Genesis HealthCare Finalizes Agreement With U.S. Department of Justice
finance.yahoo.com - June 16 at 6:06 PM |
| $53.6M settlement: Genesis Healthcare reaches deal to resolve federal lawsuits
finance.yahoo.com - June 16 at 6:06 PM |
| The Latest: Genesis HealthCare pleased to resolve probes
finance.yahoo.com - June 16 at 6:06 PM |
| Genesis HealthCare to pay $53.6M to settle US probes
finance.yahoo.com - June 16 at 6:06 PM |
| Insider Selling: Genesis Healthcare, Inc. (GEN) COO Sells 6,100 Shares of Stock
www.americanbankingnews.com - June 15 at 5:02 PM |
| Insider Selling: Genesis Healthcare, Inc. (GEN) CFO Sells 6,341 Shares of Stock
www.americanbankingnews.com - June 15 at 5:02 PM |
| Form 8-K Genesis Healthcare, Inc. For: Jun 07 - StreetInsider.com
www.streetinsider.com - June 12 at 6:14 PM |
| Form 4 Genesis Healthcare, Inc. For: Jun 07 Filed by: Hirschfeld Daniel Allen
www.streetinsider.com - June 9 at 10:51 PM |
| Form 4 Genesis Healthcare, Inc. For: Jun 07 Filed by: BLOEM JAMES H - StreetInsider.com
www.streetinsider.com - June 8 at 11:24 PM |
| Form 4 Genesis Healthcare, Inc. For: Jun 07 Filed by: Reis David A
www.streetinsider.com - June 8 at 6:24 PM |
| Genesis Healthcare Inc (GEN) Upgraded by ValuEngine to Sell
www.americanbankingnews.com - June 8 at 4:08 PM |
| Genesis Healthcare (GEN) vs. Capital Senior Living (CSU) Financial Analysis
www.americanbankingnews.com - June 7 at 4:42 PM |
| St. Clair Hospital to create accountable care organization
www.bizjournals.com - June 7 at 10:59 AM |
Genesis Healthcare (GEN) Chart for Tuesday, September, 26, 2017
